Loading...
Market
How much additional funding will Shift Bioscience secure in 2025?
3
Resolution / Starting Odds
No additional funding • 25%
Up to $10 million • 25%
$10 million to $50 million • 25%
Over $50 million • 25%
Official funding announcements from Shift Bioscience
Story
Shift Bioscience Raises $16M with Healthspan Capital to Advance AI-Driven Cell Rejuvenation Platform
Oct 15, 2024, 11:07 AM
British startup Shift Bioscience has successfully raised $16 million in seed funding to advance its AI-driven cell simulation platform. The funding will be used to identify genes that can safely rejuvenate aging cells by rewinding the epigenetic clock. This initiative aims to develop therapeutics for age-related diseases without the risks associated with Yamanaka factors. Shift Bioscience's platform leverages artificial intelligence to simulate cell behavior and identify potential gene-factors for rejuvenation. The investment was led by Healthspan Capital, marking a significant milestone for the company. Daniel / Shift Bio was the first company Healthspan Capital invested in.
View original story
Similar markets
Less than £50 million • 25%
£50 million to £100 million • 25%
£100 million to £150 million • 25%
More than £150 million • 25%
Less than $100 million • 25%
$100 million to $199 million • 25%
$200 million to $299 million • 25%
$300 million or more • 25%
Less than 50 ETH • 25%
50-100 ETH • 25%
100-150 ETH • 25%
More than 150 ETH • 25%
Yes • 50%
No • 50%
Less than $50M • 25%
$50M - $100M • 25%
$100M - $150M • 25%
More than $150M • 25%
Less than $20M • 25%
$20M to $40M • 25%
$40M to $60M • 25%
More than $60M • 25%
